GenMont Biotech Incorporation (3164.TW)
- Previous Close
20.10 - Open
20.20 - Bid 20.20 x --
- Ask 20.30 x --
- Day's Range
19.90 - 20.30 - 52 Week Range
17.20 - 25.35 - Volume
40,197 - Avg. Volume
77,668 - Market Cap (intraday)
1.748B - Beta (5Y Monthly) --
- PE Ratio (TTM)
44.89 - EPS (TTM)
0.45 - Earnings Date --
- Forward Dividend & Yield 0.80 (3.96%)
- Ex-Dividend Date Mar 27, 2025
- 1y Target Est
--
GenMont Biotech Incorporation engages in the research, development, manufacture, and sale of functional probiotic supplements in Taiwan. The company offers functional probiotics raw materials, capsules, powder, tablets, and liquid products; and original formula design and manufacturing, and equipment manufacturing services on health care food, as well as cooperates in the research, production, and clinical trial of various products. GenMont Biotech Incorporation was founded in 2000 and is headquartered in Tainan City, Taiwan.
www.genmont.com.twRecent News: 3164.TW
View MorePerformance Overview: 3164.TW
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 3164.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 3164.TW
View MoreValuation Measures
Market Cap
1.75B
Enterprise Value
1.41B
Trailing P/E
44.89
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.75
Price/Book (mrq)
1.33
Enterprise Value/Revenue
3.81
Enterprise Value/EBITDA
12.01
Financial Highlights
Profitability and Income Statement
Profit Margin
10.58%
Return on Assets (ttm)
0.73%
Return on Equity (ttm)
2.04%
Revenue (ttm)
368.41M
Net Income Avi to Common (ttm)
38.96M
Diluted EPS (ttm)
0.45
Balance Sheet and Cash Flow
Total Cash (mrq)
388.42M
Total Debt/Equity (mrq)
6.61%
Levered Free Cash Flow (ttm)
53.8M